MannKind Corp
MNKD
#5807
Rank
A$1.83 B
Marketcap
A$5.69
Share price
0.77%
Change (1 day)
-31.75%
Change (1 year)

MannKind Corp (MNKD) - P/B ratio

P/B ratio as of November 2026 : -18.7

According to MannKind Corp's latest financial reports the company has a price-to-book ratio of 3.18673.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

MannKind Corp - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-31-3.99-28%
2022-12-31-5.545.56%
2021-12-31-5.2428.28%
2020-12-31-4.09185.12%
2019-12-31-1.4326.64%
2018-12-31-1.13-11.83%
2017-12-31-1.28-22.59%
2016-12-31-1.66-6.5%
2015-12-31-1.77-93.82%
2014-12-31-28.7-54.1%
2013-12-31-62.5947.62%
2012-12-31-5.97470.27%
2011-12-31-1.05-81.14%
2010-12-31-5.55-66.79%
2009-12-31-16.7-514.44%
2008-12-314.0382.01%
2007-12-312.22-29.74%
2006-12-313.1579.01%
2005-12-311.76-48.06%
2004-12-313.39

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.96-110.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
5.26-128.18%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
29.9-260.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
8.62-146.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
82.3-540.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
1.41-107.55%๐Ÿ‡บ๐Ÿ‡ธ USA